Scribe Therapeutics, Inc. (SCTX) stock
Close on Nov 12, 2026Market cap $321.65MP/E –Yield –
Scribe Therapeutics statistics
34 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 2.57
- 2.29
Share statisticsIndustry
- Shares Change (QoQ)
- 662.0%
- 0.51%
- Float
- 8M
- 49M
- Shares Held by Insiders
- 56.0%
- 12.1%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- 49.5%
- -0.76%
- Short % of Float
- 20.1%
- 9.04%
- Short % of Shares Outstanding
- 8.83%
- 6.30%
- Days to Cover
- 4.01
- 5.13
Stock price statisticsIndustry
- 20-Day Moving Average
- $17.07
- –
- 50-Day Moving Average
- $21.42
- –
- Average True Range (14)
- $2.08
- –
- Price Change (1 Week)
- 9.75%
- 1.51%
- Price Change (1 Month)
- -18.2%
- -2.35%
- Price Change (3 Months)
- -18.0%
- -21.1%
- Average Volume (10 Days)
- 322,684
- –
- Average Volume (20 Days)
- 368,997
- –
- Average Volume (90 Days)
- 368,562
- –
- Relative Volume
- 0.76
- 0.79
- Relative Strength Index (14)
- 45.4
- 44.7
Financial positionIndustry
- Current Ratio
- 4.72
- 3.30
- Quick Ratio
- 4.59
- 2.42
Balance sheetIndustry
- Net Cash (Debt)
- $174.20M
- $17.46M
- Net Cash Per Share
- $9.20
- $0.72
- Equity (Book Value)
- $125.17M
- $53.27M
- Book Value Per Share
- $6.61
- $1.50
- Tangible Book Value
- $125.17M
- $26.82M
- Working Capital
- $140.96M
- $79.47M
Scores and fair valueIndustry
- Altman Z-Score
- 2.55
- 0.30
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | SCTX | S&P 500 | Difference | SCTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.8% | -2.7% | −15.1 pts | ||
| 3 months | -26.2% | -1.7% | −24.4 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M SCTX shares were sold short on Oct 30, 2026, up 49.5% from the previous report, or 20.05% of the shares available to trade. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 78.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,671,740 | +49.5% | 417,041 | 4.0 |
| Oct 15, 2026 | 1,118,447 | -54.7% | 474,424 | 2.4 |
| Sep 30, 2026 | 2,466,931 | +212.1% | 689,637 | 3.6 |
| Sep 15, 2026 | 790,538 | +1.6% | 173,433 | 4.6 |
| Aug 31, 2026 | 778,191 | +173.3% | 295,438 | 2.6 |
| Aug 14, 2026 | 284,711 | +8.2% | 132,875 | 2.1 |
| Jul 31, 2026 | 263,070 | – | 195,886 | 1.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?